Lake Forest, IL, United States of America

Alexander Ruggles

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: Abbvie Inc., Neurocrine Biosciences, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Ruggles: Innovator in Pharmaceutical Formulations

Introduction

Alexander Ruggles is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of women's health issues. His innovative work has led to the development of a patent that addresses critical medical conditions.

Latest Patents

Ruggles holds a patent for "Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis." This patent involves pharmaceutical compositions that comprise a gonadotropin-releasing hormone (GnRH) antagonist. The disclosure also includes methods for preparing and using these compositions, as well as techniques for facilitating the release of a GnRH antagonist from a pharmaceutical formulation. He has 1 patent to his name.

Career Highlights

Throughout his career, Ruggles has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AbbVie Inc. and Neurocrine Biosciences, Inc. His work in these organizations has allowed him to contribute to advancements in medical treatments.

Collaborations

Ruggles has collaborated with several professionals in his field, including Hui Zu and Jared A. Baird. These collaborations have further enriched his research and development efforts.

Conclusion

Alexander Ruggles is a distinguished inventor whose work in pharmaceutical formulations has the potential to improve the lives of many individuals suffering from women's health issues. His innovative contributions continue to shape the future of medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…